1. Korhonen, Emilia A, Murtomäki, Aino, Jha, Sawan Kumar, Mäkinen, Taija, Alitalo, Kari. . Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression. In The Journal of clinical investigation, 132, . doi:10.1172/JCI155478. https://pubmed.ncbi.nlm.nih.gov/35763346/
2. Reilly, John P, Wang, Fan, Jones, Tiffanie K, Feng, Rui, Meyer, Nuala J. 2018. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. In Intensive care medicine, 44, 1849-1858. doi:10.1007/s00134-018-5328-0. https://pubmed.ncbi.nlm.nih.gov/30343317/
3. Liu, Zhao-Liang, You, Cai-Lian, Wang, Biao, Zheng, Hou-Bing, Zhang, Yan-Ding. 2016. Construction of Ang2-siRNA chitosan magnetic nanoparticles and the effect on Ang2 gene expression in human malignant melanoma cells. In Oncology letters, 11, 3992-3998. doi:. https://pubmed.ncbi.nlm.nih.gov/27313729/
4. Huang, Yangyang, Zhou, Xujiao, Zhang, Yirou, Zhang, Chuan, Hong, Jiaxu. 2024. A Nucleic Acid-Based LYTAC Plus Platform to Simultaneously Mediate Disease-Driven Protein Downregulation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2306248. doi:10.1002/advs.202306248. https://pubmed.ncbi.nlm.nih.gov/38251411/
5. Zhou, Xingyan, Pucel, Jenna C, Nomura-Kitabayashi, Aya, Marambaud, Philippe, Meadows, Stryder M. 2023. ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia. In Arteriosclerosis, thrombosis, and vascular biology, 43, 1384-1403. doi:10.1161/ATVBAHA.123.319385. https://pubmed.ncbi.nlm.nih.gov/37288572/
6. Kuriyama, Aika, Nakamura, Shinsuke, Inokuchi, Yuta, Shimazawa, Masamitsu, Hara, Hideaki. 2024. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice. In European journal of pharmacology, 976, 176691. doi:10.1016/j.ejphar.2024.176691. https://pubmed.ncbi.nlm.nih.gov/38821166/
智鼠故事 
